Wanjia Group Holdings Ltd
HKEX:401
Relative Value
The Relative Value of one Wanjia Group Holdings Ltd stock under the Base Case scenario is 0.175 HKD. Compared to the current market price of 0.063 HKD, Wanjia Group Holdings Ltd is Undervalued by 64%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Wanjia Group Holdings Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
HK |
Wanjia Group Holdings Ltd
HKEX:401
|
35.3m HKD | 0.2 | 27.7 | 10.2 | 10.2 | ||
US |
Mckesson Corp
NYSE:MCK
|
71.2B USD | 0.2 | 23.7 | 16.5 | 19.1 | ||
US |
Cencora Inc
NYSE:COR
|
48B USD | 0.2 | 25.7 | 13.2 | 18.5 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
25.2B USD | 0.1 | 39.4 | 8.8 | 11.9 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD | 0.8 | 22.7 | 11.9 | 16 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
67.3B HKD | 0.1 | 7 | 1.7 | 2 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.3B CNY | 1.4 | 21.2 | 15.5 | 15.5 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 3.1 | 45.9 | 14.8 | 29.2 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
50.8B CNY | 0.2 | 13.5 | 8 | 8 |